Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Global Forecast 2024-2030

Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Global Forecast 2024-2030


The Immuno Oncology Assays Market size was estimated at USD 6.26 billion in 2023 and expected to reach USD 7.21 billion in 2024, at a CAGR 15.26% to reach USD 16.93 billion by 2030.

Global Immuno Oncology Assays Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immuno Oncology Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immuno Oncology Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immuno Oncology Assays Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, Charles River Laboratories International, Inc., ElsaLys Biotech S.A., Eurofins DiscoverX Products, LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck KGaA, NanoString Technologies, Inc., NeoGenomics Laboratories, Inc., PerkinElmer, Inc., QIAGEN GmbH, Sartorius AG, Thermo Fisher Scientific, Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Immuno Oncology Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
Bladder Cancer

Colorectal Cancer

Lung Cancer

Melanoma

Product
Consumables

Software

Technology
Flow Cytometry

Immunoassay

Next-Generation Sequencing

Polymerase Chain Reaction

Application
Clinical Diagnostics

Research

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Immuno Oncology Assays Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immuno Oncology Assays Market?
3. What are the technology trends and regulatory frameworks in the Immuno Oncology Assays Market?
4. What is the market share of the leading vendors in the Immuno Oncology Assays Market?
5. Which modes and strategic moves are suitable for entering the Immuno Oncology Assays Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Immuno Oncology Assays Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of cancer and adoption of targeted therapy over other treatment options
5.1.1.2. Development of bioinformatic tools enhancing the drug development process
5.1.1.3. Rise in healthcare expenditure and healthcare insurance
5.1.2. Restraints
5.1.2.1. Unfavorable regulatory and reimbursement scenario
5.1.3. Opportunities
5.1.3.1. Technological advancement and R&D for the treatment of cancer
5.1.3.2. Emergence of companion diagnostics
5.1.4. Challenges
5.1.4.1. Lack of healthcare professions for device operation
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Immuno Oncology Assays Market, by Indication
6.1. Introduction
6.2. Bladder Cancer
6.3. Colorectal Cancer
6.4. Lung Cancer
6.5. Melanoma
7. Immuno Oncology Assays Market, by Product
7.1. Introduction
7.2. Consumables
7.3. Software
8. Immuno Oncology Assays Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.3. Immunoassay
8.4. Next-Generation Sequencing
8.5. Polymerase Chain Reaction
9. Immuno Oncology Assays Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Research
10. Americas Immuno Oncology Assays Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Immuno Oncology Assays Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.
10. South Korea
11.
11. Taiwan
11.
12. Thailand
11.
13. Vietnam
12. Europe, Middle East & Africa Immuno Oncology Assays Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.
10. Nigeria
12.
11. Norway
12.
12. Poland
12.
13. Qatar
12.
14. Russia
12.
15. Saudi Arabia
12.
16. South Africa
12.
17. Spain
12.
18. Sweden
12.
19. Switzerland
12.
20. Turkey
12.
21. United Arab Emirates
12.
22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. Bio-Rad Laboratories, Inc.
14.1.3. BioAgilytix Labs, LLC
14.1.4. Charles River Laboratories International, Inc.
14.1.5. ElsaLys Biotech S.A.
14.1.6. Eurofins DiscoverX Products, LLC
14.1.7. HTG Molecular Diagnostics, Inc.
14.1.8. Illumina, Inc.
14.1.9. Merck KGaA
14.1.
10. NanoString Technologies, Inc.
14.1.
11. NeoGenomics Laboratories, Inc.
14.1.
12. PerkinElmer, Inc.
14.1.
13. QIAGEN GmbH
14.1.
14. Sartorius AG
14.1.
15. Thermo Fisher Scientific, Inc.
14.1.
16. Twist Bioscience Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. IMMUNO ONCOLOGY ASSAYS MARKET RESEARCH PROCESS
FIGURE 2. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNO ONCOLOGY ASSAYS MARKET DYNAMICS
FIGURE 7. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings